Southlake, TX, United States of America

Renibus Therapeutics, Inc.


USPTO Granted Patents = 11


Trademarks = 1

Forward Citations = 5

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Donald Jeffrey Keyser (10 out of 36 patents)

silverMedal Alvaro F Guillem (10 out of 30 patents)

bronzeMedal Richard A Zager (9 out of 14 patents)

4.  Bhupinder Singh (5 out of 9 patents)

5.  Eric F Connor (1 out of 45 patents)

6.  Randi K Gbur (1 out of 13 patents)

7.  Matthew J Kade (1 out of 13 patents)

8.  Paul H Kierstead (1 out of 13 patents)

9.  Jerry M Buysse (1 out of 28 patents)

10.  Kalpesh N Biyani (1 out of 24 patents)

11.  Son H Nguyen (1 out of 18 patents)

12.  Scott M Tabakman (1 out of 29 patents)

13.  Gerrit Klaerner (1 out of 50 patents)

14.  Stacey Ruiz (1 out of 1 patent)

15.  Michael J Cope (1 out of 1 patent)


11 patents:

Company Overview
Renibus Therapeutics, Inc. is a biopharmaceutical company based in Southlake, Texas, focused on developing innovative therapies for patients with unmet medical needs. The company specializes in advancing treatments that target various diseases, leveraging its expertise in drug development and clinical research. Renibus is committed to improving patient outcomes through its proprietary technologies and therapeutic approaches, aiming to address critical health challenges in the medical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#5 in Southlake, TX

#1,725 in Texas

#27,514 in US

#51,761 in the World

Southlake, TX (US)
Southlake, TX, United States of America
Forward Citations = 5

15 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Renibus Therapeutics, Inc.. Retrieved from https://idiyas.com/company/renibus-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…